Has Jason Brancato received payments from drug or device companies?

Yes. Drug and device makers reported $10,107 in general payments to Jason Brancato across 580 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jason Brancato did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jason Brancato come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jason Brancato

Medical · Bellmore, NYNPI 1407000854

Payments from drug & device makers

$10,107in general payments, 2019–2025

Across 580 payments — averaging $17.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Amgen$1K
AstraZeneca$1K
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
Lilly USA, LLC$851
Boehringer Ingelheim$528
plus $4K from 48 others

What the payments were for

Food & beverage$9,94298%
Education$1652%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	101	$1,529
Amgen	75	$1,130
AstraZeneca	50	$1,033
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	71	$1,008
Lilly USA, LLC	47	$851
Boehringer Ingelheim	30	$528
Pfizer	27	$476
Novo Nordisk	24	$385
Dermavant Sciences, Inc.	15	$224
Bayer	8	$186
Johnson & Johnson	10	$184
Lundbeck LLC	7	$178
Teva Pharmaceuticals USA, Inc.	2	$165
Intra-sana Laboratories	2	$145
Axsome Therapeutics, Inc.	5	$123
Merck	5	$116
GSK	6	$108
Cumberland Pharmaceuticals, Inc.	7	$100
Sanofi-aventis U.S. LLC	5	$95
Esperion Therapeutics, Inc.	5	$88
Intuity Medical Inc	5	$82
Paratek Pharmaceuticals, Inc.	4	$81
Kowa Pharmaceuticals America, Inc.	6	$77
Biohaven Pharmaceutical Holding Company Ltd.	3	$74
Takeda Pharmaceuticals U.S.A., Inc.	3	$73
Corcept Therapeutics	4	$72
Almirall LLC	4	$71
Abbott	3	$68
Novartis	4	$67
Biohaven Pharmaceuticals, Inc.	3	$58
Amarin Pharma, Inc.	3	$55
Incyte Corporation	3	$51
Arcutis Biotherapeutics, Inc.	3	$50
Corium, LLC	3	$50
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	2	$48
Dexcom, Inc.	2	$47
Antares Pharma, Inc.	2	$41
Botanix SB Inc	2	$39
Azurity Pharmaceuticals, Inc.	2	$37
Idorsia Pharmaceuticals US Inc	2	$33
Currax Pharmaceuticals LLC	2	$31
Bioxcel Therapeutics, Inc.	1	$28
Arbor Pharmaceuticals, Inc.	1	$25
Genentech USA, Inc.	1	$23
Exact Sciences	1	$22
Sumitomo Pharma America, Inc.	1	$20
Clarus Therapeutics Inc.	1	$20
Phadia US Inc.	1	$19
Alkermes, Inc.	1	$17
Shield Therapeutics Inc	1	$16
Ardelyx, Inc.	1	$15
Vistapharm, Inc.	1	$15
Radius Health, Inc.	1	$15
Indivior Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,107 in reported general payments places this provider in the 95th percentile of 2,395 medical providers in New York.

See all medical providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
MounjaroTirzepatide	43	$66,793
WegovySemaglutide	24	$33,883
Methylprednisolone	59	$547
Levothyroxine Sodium	23	$503
Olmesartan-HydrochlorothiazideOlmesartan/Hydrochlorothiazide	14	$386
Metoprolol Succinate	14	$239
Rosuvastatin Calcium	23	$214
Azithromycin	26	$143
Sertraline Hcl	15	$135
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	12	$77
Amlodipine Besylate	21	$76
Atorvastatin Calcium	16	$72

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Lilly USA, LLCMounjaro	$851	$66,79343 claims
Novo NordiskWegovy	$385	$33,88324 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,395 medical providers in New York.

Other medical in Bellmore

Rebecca EllwoodAlbany$565K
Denisse SerranoCortlandt Manor$255K
Michele Kissous-HuntNew York$246K
Laura MaroldoNew York$126K
Carl ClarkeBrooklyn$116K
Maureen ThyneNew York$109K
Gina FriesRochester$106K
Ilse StraussSmithtown$87K
Helen AdamsNew York$87K
Hailey BrickmanNew York$82K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →